Hyperinsulinism / fetma

Method for treating insulin resistance, abdominal obesity, hypertension, hyperinsulinemia, and elevated blood lipids with a cortisol inhibitor

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

The present invention relates to the use of ketoconazole or molecules resembling ketoconazole but with some side-chains, not affecting the biological activity compared to ketoconazole, changed for manufacturing drugs for treatment of diabetes mellitus type II. The drug ketoconazole (e.g., under the

Method for treating insulin resistance, abdominal obesity, hypertension, hyperinsulinemia, and elevated blood lipids with a cortisol inhibitor

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

The present invention relates to the use of ketoconazole or molecules resembling ketoconazole but with some side-chains, not affecting the biological activity compared to ketoconazole, changed for manufacturing drugs for treatment of diabetes mellitus type II. The drug ketoconazole (e.g., under the

Therapeutic package for the long term reduction of body fat stores insulin resistance hyperinsulinemia and hyperglycemia in vertebrates

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

1. Field of the Invention This invention relates to an improved process for the reduction in vertebrates, animals or humans, of body fat stores, and reduction of insulin resistance, hyperinsulinemia, which is often associated with insulin resistance, and hyperglycemia, or reduction of plasma

Methods for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates with a prolactin stimulatory compound

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

FIELD OF THE INVENTION This invention relates to an improved process for the reduction in vertebrates, animals or humans, of body fat stores, and reduction of insulin resistance, hyperinsulinemia, which is often associated with insulin resistance, and hyperglycemia, or reduction of plasma glucose.

Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

FIELD OF THE INVENTION This invention relates to an improved process for the reduction in vertebrates, animals or humans, of body fat stores, and reduction of insulin resistance, hyperinsulinemia, which is often associated with insulin resistance, and hyperglycemia, or reduction of plasma glucose.

Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

FIELD OF THE INVENTION This invention relates to an improved process for the reduction in vertebrates, animals or humans, of body fat stores, and reduction of insulin resistance, hyperinsulinemia, which is often associated with insulin resistance, and hyperglycemia, or reduction of plasma glucose.

Method for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

FIELD OF THE INVENTION This invention relates to an improved process for the reduction in vertebrates, animals or humans, of body fat stores, and reduction of insulin resistance, hyperinsulinemia, which is often associated with insulin resistance, and hyperglycemia, or reduction of plasma glucose.

Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia in vertebrates

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

FIELD OF THE INVENTION This invention relates to a process for the reduction in animals, and humans, of body fat stores, and reduction of insulin resistance, as well as hyperinsulinemia, which is often associated with insulin resistance. In particular, it relates to timed hormonal injections to

Process for the long term reduction of body fat stores, insulin resistance, and hyperinsulinemia in vertebrates

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

FIELD OF THE INVENTION This invention relates to a process for the reduction in animals, and humans, of body fat stores, and reduction of insulin resistance, as well as hyperinsulinemia, which is often associated with insulin resistance. In particular, it relates to timed hormonal injections to

Process for the long term reduction of body fat stores, insulin resistance, and hyperinsulinemia in vertebrates

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

FIELD OF THE INVENTION This invention relates to a process for the reduction in animals, and humans, of body fat stores, and reduction of insulin resistance, as well as hyperinsulinemia, which is often associated with insulin resistance. In particular, it relates to timed hormonal injections to

Process for the long term reduction of body fat stores, insulin resistance, and hyperinsulinemia in vertebrates

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

1. FIELD OF THE INVENTION This invention relates to a process for the reduction in animals, and humans, of body fat stores, and reduction of insulin resistance, as well as hyperinsulinemia, which is often associated with insulin resistance. In particular, it relates to timed hormonal injections to

Treatments for obesity and methods for identifying compounds useful for treating obesity

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

FIELD OF THE INVENTION The present invention provides methods of treating obesity, sexual dysfunction (including erectile dysfunction), diabetes, insulin resistance, hyperinsulinemia, Syndrome X, adrenal dysfunction, hypertension, hypercholesterolemia, atherosclerosis, hyperlipoproteinemia,

Treatments for obesity and methods for identifiying compounds useful for treating obesity

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

FIELD OF THE INVENTION The present invention provides methods of treating obesity, sexual dysfunction (including erectile dysfunction), diabetes, insulin resistance, hyperinsulinemia, Syndrome X, adrenal dysfunction, hypertension, hypercholesterolemia, atherosclerosis, hyperlipoproteinemia,

Nerve stimulation for treatment of obesity, metabolic syndrome, and Type 2 diabetes

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

The entireties of all of these priority applications are hereby incorporated by reference. BACKGROUND OF THE INVENTION Obesity is an epidemic in the U.S. with a prevalence of about 20 percent. Annual U.S. healthcare costs associated with obesity are estimated to exceed $200 billion dollars. Obesity

Method for treatment of obesity using prolactin modulators and diet

Endast registrerade användare kan översätta artiklar

Logga in Bli medlem

FIELD OF THE INVENTION This invention relates to an improved method for the reduction in a subject, vertebrate animal or human, of weight and/or body fat stores. This method involves a reduction in caloric intake, in combination with the administration of a prolactin inhibitor. In another aspect,

hyperinsulinism/fetma

Method for treating insulin resistance, abdominal obesity, hypertension, hyperinsulinemia, and elevated blood lipids with a cortisol inhibitor

Method for treating insulin resistance, abdominal obesity, hypertension, hyperinsulinemia, and elevated blood lipids with a cortisol inhibitor

Therapeutic package for the long term reduction of body fat stores insulin resistance hyperinsulinemia and hyperglycemia in vertebrates

Methods for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates with a prolactin stimulatory compound

Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates

Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates

Method for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates

Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia in vertebrates

Process for the long term reduction of body fat stores, insulin resistance, and hyperinsulinemia in vertebrates

Process for the long term reduction of body fat stores, insulin resistance, and hyperinsulinemia in vertebrates

Process for the long term reduction of body fat stores, insulin resistance, and hyperinsulinemia in vertebrates

Treatments for obesity and methods for identifying compounds useful for treating obesity

Treatments for obesity and methods for identifiying compounds useful for treating obesity

Nerve stimulation for treatment of obesity, metabolic syndrome, and Type 2 diabetes

Method for treatment of obesity using prolactin modulators and diet

Den mest kompletta databasen med medicinska örter som stöds av vetenskapen